Travogen

Leaflet attached to the packaging: patient information

Warning! Keep the leaflet! Information on the immediate packaging in a foreign language.

Travogen, 10 mg/g (1%), cream

Isoconazole nitrate

Read the leaflet carefully before using the medicine, as it contains important information for the patient.

• Keep this leaflet, so that you can read it again if necessary.
• In case of any further doubts, consult a doctor or pharmacist.
• This medicine has been prescribed specifically for you. Do not pass it on to others. The medicine may harm another person, even if their symptoms are the same.
• If the patient experiences any side effects, including any side effects not listed in this leaflet, they should inform their doctor or pharmacist. See section 4.

Table of contents of the leaflet:

• 1. What is Travogen and what is it used for
• 2. Important information before using Travogen
• 3. How to use Travogen
• 4. Possible side effects
• 5. How to store Travogen
• 6. Package contents and other information

1. What is Travogen and what is it used for

Travogen cream is an antifungal medicine for topical use on the skin.
The active substance of the medicine, isoconazole nitrate, has an antifungal effect on various species of fungi
causing skin infections in humans, such as dermatophytes, yeasts, yeast-like fungi
(including those causing pityriasis versicolor), molds, and fungi causing seborrheic dermatitis.

Indications for use

Superficial fungal skin infections, e.g., skin fungus of the hands, feet, groin, genital area; pityriasis versicolor; seborrheic dermatitis.

2. Important information before using Travogen

When not to use Travogen:

Warnings and precautions

• Before starting to use Travogen, discuss it with your doctor or pharmacist.
• Avoid contact of the medicine with the eyes. If the medicine gets into the eyes, rinse them immediately with a large amount of water.
• To avoid re-infection, personal clothing (including towels for the body and face) should be changed daily and boiled. It is recommended to use cotton products.
• Effective treatment with Travogen depends on proper personal hygiene. In foot fungus, the interdigital space should be thoroughly dried after each washing. Socks and stockings should be changed daily.
• If Travogen is used in the genital area, some of the excipients contained in this medicine may damage condoms and diaphragms. Therefore, they may not be effective as contraceptive measures or protection against sexually transmitted diseases, such as HIV infection. For more information, consult a doctor or pharmacist.

Travogen and other medicines

Tell your doctor or pharmacist about all medicines you are currently taking or have recently taken,
as well as any medicines you plan to take.
There are no studies on the interaction of Travogen with other medicines.

Pregnancy, breastfeeding, and fertility

In pregnancy and during breastfeeding, or if you suspect you are pregnant, or if you plan to become pregnant, consult your doctor or pharmacist before using this medicine.
Pregnancy
The doctor will exercise caution when prescribing this medicine to pregnant women.
Breastfeeding
Women who are breastfeeding may use Travogen only if, in the doctor's opinion, the benefits of using the medicine for the mother outweigh the potential risks for the child.
If the doctor decides to use Travogen in a breastfeeding woman, it should not be applied to the breast area to prevent the child from ingesting the medicine.
Fertility
There is no data indicating that the use of Travogen affects fertility.

Driving and using machines

Travogen does not affect the ability to drive vehicles or operate machinery.

Travogen contains cetyl alcohol

This substance may cause skin reactions (e.g., contact dermatitis).

3. How to use Travogen

Always use this medicine exactly as your doctor has told you. If you are not sure, ask your doctor or pharmacist.
Travogen is for topical use on the skin only.
Travogen is usually applied once a day to the affected skin area.
Typically, fungal infections are treated for a period of two to three weeks. In difficult-to-treat infections (especially interdigital infections), the treatment time may be extended by the doctor to four weeks. Longer treatment periods are also possible.
In the case of interdigital fungal infections of the hands and feet, it is recommended to place a gauze strip coated with Travogen between the fingers or toes.
To avoid recurrence of fungal infection, treatment should be continued for at least two weeks after the symptoms of the disease have disappeared.
It is very important for the effectiveness of Travogen treatment to follow the principles of hygiene daily (see "Warnings and precautions").
Children and adolescents
No dose adjustment is necessary when administering Travogen to infants, children, and adolescents.

Using more than the recommended dose of Travogen

Single use of the medicine on a large skin area or accidental ingestion does not pose a risk of acute poisoning. If you have any doubts, consult a doctor or pharmacist.

Missing a dose of Travogen

Do not use a double dose to make up for a missed dose. If you miss a dose, apply the next dose as soon as possible, and then continue treatment as recommended.
If you have any further doubts about using this medicine, consult a doctor or pharmacist.

4. Possible side effects

Like all medicines, Travogen can cause side effects, although not everybody gets them.
Side effects are listed by frequency of occurrence:
Common:may affect up to 1 in 10 people

• Skin irritation or burning at the application site.

Uncommon:may affect up to 1 in 100 people

• Itching or excessive dryness of the skin at the application site; weeping changes, small fluid-filled blisters (dyshidrotic eczema), skin inflammation (contact dermatitis).

Rare:may affect up to 1 in 1,000 people

• Swelling at the application site, skin cracks.

Frequency not known:

• Redness (erythema) or blisters at the application site, allergic skin reactions.

Reporting side effects

If you experience any side effects, including any side effects not listed in this leaflet, inform your doctor or pharmacist. Side effects can be reported directly to the Department of Monitoring of Adverse Reactions to Medicinal Products of the Office for Registration of Medicinal Products, Medical Devices, and Biocidal Products,
Al. Jerozolimskie 181C, 02-222 Warsaw, tel.: +48 22 49 21 301, fax: +48 22 49 21 309,
website: https://smz.ezdrowie.gov.pl.
Reporting side effects will help gather more information on the safety of the medicine.

5. How to store Travogen

Do not store above 30°C.
Keep the medicine out of the sight and reach of children.
Do not use this medicine after the expiry date stated on the packaging. The expiry date refers to the last day of the month.
Shelf life after first opening the tube - 3 months.
Medicines should not be disposed of via wastewater or household waste. Ask your pharmacist how to dispose of medicines no longer required. This will help protect the environment.

6. Package contents and other information

What Travogen contains

• The active substance of the medicine is isoconazole nitrate. 1 g of cream contains 10 mg of isoconazole nitrate.
• The other ingredients of the medicine are: polysorbate 60, sorbitan stearate, cetyl alcohol, liquid paraffin, white petrolatum, purified water.

What Travogen looks like and what the package contains

Travogen is a white to slightly yellowish, non-transparent cream.
The package of the medicine is an aluminum tube coated internally with epoxy resin, closed with a high-density polyethylene (HDPE) cap, containing 30 g of cream, placed in a cardboard box.

Marketing authorization holder in Austria, the country of export:

LEO Pharma A/S, Industriparken 55, 2750 Ballerup, Denmark

Manufacturer:

LEO Pharma Manufacturing Italy S.r.l., Via E. Schering 21, 20090 Segrate (Milan), Italy

Parallel importer:

InPharm Sp. z o.o., ul. Strumykowa 28/11, 03-138 Warsaw

Repackaged by:

InPharm Sp. z o.o. Services sp. k., ul. Chełmżyńska 249, 04-458 Warsaw
Austrian marketing authorization number, country of export:1-16910

Parallel import authorization number: 185/24

Date of leaflet approval: 07.05.2024

[Information about the trademark]